Compare COMBAT DRUGS with SYNCOM FORMULATIONS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

COMBAT DRUGS vs SYNCOM FORMULATIONS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    COMBAT DRUGS SYNCOM FORMULATIONS COMBAT DRUGS/
SYNCOM FORMULATIONS
 
P/E (TTM) x 17.1 25.8 66.3% View Chart
P/BV x 2.6 4.6 56.2% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 COMBAT DRUGS   SYNCOM FORMULATIONS
EQUITY SHARE DATA
    COMBAT DRUGS
Mar-20
SYNCOM FORMULATIONS
Mar-21
COMBAT DRUGS/
SYNCOM FORMULATIONS
5-Yr Chart
Click to enlarge
High Rs344 853.8%   
Low Rs161 2,531.3%   
Sales per share (Unadj.) Rs23.73.1 766.3%  
Earnings per share (Unadj.) Rs1.10.4 295.2%  
Cash flow per share (Unadj.) Rs1.60.4 390.3%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs12.42.3 552.5%  
Shares outstanding (eoy) m10.10789.95 1.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.10.7 141.6%   
Avg P/E ratio x23.16.3 367.6%  
P/CF ratio (eoy) x15.35.5 278.0%  
Price / Book Value ratio x2.01.0 196.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m2541,833 13.9%   
No. of employees `000NANA-   
Total wages/salary Rs m196183 106.7%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m2402,448 9.8%  
Other income Rs m371 3.8%   
Total revenues Rs m2432,519 9.6%   
Gross profit Rs m25380 6.6%  
Depreciation Rs m640 13.8%   
Interest Rs m84 198.2%   
Profit before tax Rs m15407 3.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4115 3.2%   
Profit after tax Rs m11292 3.8%  
Gross profit margin %10.515.5 67.8%  
Effective tax rate %24.928.3 87.9%   
Net profit margin %4.611.9 38.5%  
BALANCE SHEET DATA
Current assets Rs m2441,996 12.2%   
Current liabilities Rs m2301,065 21.6%   
Net working cap to sales %5.638.0 14.6%  
Current ratio x1.11.9 56.4%  
Inventory Days Days117100 116.9%  
Debtors Days Days222111,558,597 0.0%  
Net fixed assets Rs m1271,018 12.4%   
Share capital Rs m101790 12.8%   
"Free" reserves Rs m25988 2.5%   
Net worth Rs m1261,778 7.1%   
Long term debt Rs m00-   
Total assets Rs m3703,014 12.3%  
Interest coverage x2.9105.4 2.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.8 79.8%   
Return on assets %5.19.8 51.6%  
Return on equity %8.816.4 53.4%  
Return on capital %17.823.1 77.2%  
Exports to sales %069.7 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,707 0.0%   
Imports (cif) Rs mNA4 0.0%   
Fx inflow Rs m01,707 0.0%   
Fx outflow Rs m04 0.0%   
Net fx Rs m01,704 0.0%   
CASH FLOW
From Operations Rs m-152-20 761.7%  
From Investments Rs m-1-727 0.2%  
From Financial Activity Rs m180720 25.1%  
Net Cashflow Rs m28-27 -104.1%  

Share Holding

Indian Promoters % 0.0 41.2 -  
Foreign collaborators % 45.9 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 54.1 58.8 92.0%  
Shareholders   12,796 38,547 33.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare COMBAT DRUGS With:   BDH INDUS.  ALPA LAB  SOLARA ACTIVE PHARMA SCIENCES  CAPLIN POINT  ALKEM LABORATORIES  



Today's Market

Sensex Ends 456 Points Lower; Midcap and Smallcap Stocks Witness Heavy Selling(Closing)

After opening the day on a flat note, Indian share markets witnessed heavy selling in the afternoon session and ended lower.

Related Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

Modi's Big Move Could Boost these 5 Defence Stocks(Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

COMBAT DRUGS SHARE PRICE


Oct 20, 2021 (Close)

TRACK COMBAT DRUGS

  • Track your investment in COMBAT DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMBAT DRUGS 8-QTR ANALYSIS

COMPARE COMBAT DRUGS WITH

MARKET STATS